Navigation Links
Amgen's Fourth Quarter 2008 Adjusted Earnings Per Share Increased 6 Percent to $1.06; Full Year 2008 Adjusted Earnings Per Share Increased 6 Percent to $4.55
Date:1/26/2009

------------ ------------ 2008 2007 2008 2007 ---- ---- ---- ---- Aranesp(R) - U.S. $361 $462 $1,651 $2,154 Aranesp(R) - International 345 365 1,486 1,460 EPOGEN(R) - U.S. 646 638 2,456 2,489 Neulasta(R) - U.S. 655 607 2,505 2,351 NEUPOGEN(R) - U.S. 229 225 896 861 Neulasta(R) - International 193 177 813 649 NEUPOGEN(R) - International 103 109 445 416 Enbrel(R) - U.S. 858 805 3,389 3,052 Enbrel(R) - International 55 51 209 178 Sensipar(R) - U.S. 106 92 412 333 Sensipar(R) - International 47 36 185 130 Vectibix(R) - U.S. 25 33 108 170 Vectibix(R) - International 21 - 45 - Other product sales - U.S. 20 9 43 33 Other product sales - International 10 9 44 35 -- --- -- -- Total product sales $3,674 $3,618 $14,687 $14,311 ====== ====== ======= ======= U.S. $2,900 $2,871 $11,460 $11,443 International 774 747 3,227 2,868 --- --- ----- ----- Total product sales $3,674 $3,618 $14,687 $14,311 ====== ====== ======= ======= Amgen
'/>"/>
SOURCE Amgen
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27

Related biology technology :

1. Beckman Coulter Announces Fourth Quarter 2008 Earnings to be Released on Monday, February 9, 2009, After Market Closes
2. Amgen Announces Webcast of 2008 Fourth Quarter and Full Year Financial Results
3. Caliper Life Sciences Announces Preliminary 2008 Fourth Quarter and Full Year Revenue Results
4. Cepheid Announces Preliminary 2008 Fourth Quarter and Full Year Revenue Results
5. Orexigen(R) Therapeutics Issued a Key Fourth U.S. Patent on Contrave(R)
6. BioMed Realty Trust Declares Fourth Quarter 2008 Common Stock and Preferred Stock Dividends
7. Martek Announces Fourth Quarter and FY 2008 Financial Results
8. Martek to Announce Fourth Quarter and Fiscal Year 2008 Results
9. Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results
10. Hill-Rom Reports Fourth Quarter Revenue Growth of 14.1 Percent to $424 Million and Adjusted Earnings Per Fully Diluted Share From Continuing Operations of $0.58, an Increase of 52.6 Percent From the Prior Year
11. Varian, Inc. Reports Strong Fourth Quarter 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... (PRWEB) March 02, 2015 Outside GC, ... today announced the addition of Debbie Casey as a ... in the healthcare space. , Debbie has ... of which with Fresenius Medical Care North America in ... her extensive experience to work with Outside GC’s growing ...
(Date:2/27/2015)... SUMMERLAND, British Columbia , Feb. 27, 2015 ... ), a leader in synthetic biology, today announced it ... Fruits (OSF), the pioneering agricultural company behind the ... non-browning apple. Through the acquisition, Intrexon expands its food ... appetizing and convenient for consumers while providing economic benefit ...
(Date:2/27/2015)... Scotia (PRWEB) February 27, 2015 ... vaccine and immunotherapy company, today announced that the ... application for Fast Track designation and Phase I ... in conjunction with the mutual co-development agreement signed ... obtained Fast Track designation for the DPX-Survivac. , ...
(Date:2/27/2015)... 2015 FamilyFarms Group is pleased to ... State Line Farms, received the 2015 Tomorrow’s Top Producer ... the age of 35, who has demonstrated excellence in ... to win the Tomorrow's Top Producer Horizon Award. Every ... Top Producer Award and learning from their experiences. It ...
Breaking Biology Technology:Outside GC Expands Healthcare Team 2Intrexon to Acquire Okanagan Specialty Fruits 2Intrexon to Acquire Okanagan Specialty Fruits 3Intrexon to Acquire Okanagan Specialty Fruits 4Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 2Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 3Matt Sims Receives the 2015 Tomorrow’s Top Producer Horizon Award 2
... PALO ALTO, Calif., Aug. 28 Avicena ... biotechnology company that,develops central nervous system therapeutics ... announced today that it has signed an,exclusive ... leading,supplier of specialty chemicals to the personal ...
... 128-compliant label,design and printing software solutions to healthcare providers, blood banks ... ... Niceware(R) International, LLC is,excited to announce that ICCBBA, Inc. granted ... labeling,software solutions that support ISBT 128-compliant data structures and bar,codes. ...
... With 3.8 Million Patients ... ... Slightly Accretive to Medco Shareholders in ... 2008, FRANKLIN LAKES, N.J. and WAKEFIELD, Mass., Aug. 28 ,Medco Health ...
Cached Biology Technology:Avicena Signs Worldwide Exclusive Distribution Agreement with RITA Corporation for its Proprietary Dermaceutical Compounds 2Avicena Signs Worldwide Exclusive Distribution Agreement with RITA Corporation for its Proprietary Dermaceutical Compounds 3Avicena Signs Worldwide Exclusive Distribution Agreement with RITA Corporation for its Proprietary Dermaceutical Compounds 4Niceware International Announces Licensed Vendor Status with ICCBBA, Inc. to Provide ISBT 128-compliant Software 2Medco Announces Agreement to Acquire Diabetes Care Leader PolyMedica in Transaction Valued at $1.5 Billion 2Medco Announces Agreement to Acquire Diabetes Care Leader PolyMedica in Transaction Valued at $1.5 Billion 3Medco Announces Agreement to Acquire Diabetes Care Leader PolyMedica in Transaction Valued at $1.5 Billion 4Medco Announces Agreement to Acquire Diabetes Care Leader PolyMedica in Transaction Valued at $1.5 Billion 5Medco Announces Agreement to Acquire Diabetes Care Leader PolyMedica in Transaction Valued at $1.5 Billion 6Medco Announces Agreement to Acquire Diabetes Care Leader PolyMedica in Transaction Valued at $1.5 Billion 7
(Date:2/5/2015)... Conn. , Jan. 26, 2015 NXT-ID, Inc. ... the "Company"), a biometric authentication company focused on the ... new corporate website ( http://www.nxt-id.com/ ) as part of ... smart wallet. The Company launched its new consumer website ... Gino Pereira , CEO of NXT-ID said, "Our new ...
(Date:2/5/2015)... DUBLIN , Jan. 28, 2015 Research ... announced the addition of the "Global Biometrics ... Use, Regions and Countries " report to their ... market, Asia-Pacific is anticipated ... by 2015, owing to increasing government spending towards ...
(Date:1/22/2015)... , Jan. 9, 2015 Valid S.A. ("Company") (BM&FBOVESPA: ... market in general the State of Washington,s ... for a new enrollment and central issuance system for driver,s ... The project planning and development will start in ...
Breaking Biology News(10 mins):NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 2NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 3Global Biometrics Market (2014-2020): Market Forecast By Technologies, Applications, End Use, Regions and Countries 2Global Biometrics Market (2014-2020): Market Forecast By Technologies, Applications, End Use, Regions and Countries 3Valid USA Signs Contract For Washington Driver's License Issuance 2
... May 4, 2012 Young men who play volleyball, basketball ... more increase bone mass and might gain protection from developing ... the May issue of the Journal of Bone and ... investigation of its kind, discovered that young men who actively ...
... Sloppy shipping of a donated human retina to an ... loss has inadvertently helped uncover a previously undetected mechanism ... urge review of how millions of dollars are spent ... degeneration called choroidal neovascularization. Working at IU,s ...
... patients are treated with a drug called tamoxifen. The ... the growth signals of this hormone in cancer cells. ... their growth program: They change their behavior and shape, ... invade surrounding tissue. Scientists working with PD (Associate Professor) ...
Cached Biology News:Study: Men who do load-bearing exercise in early 20s may be shielded from osteoporosis 2Study: Men who do load-bearing exercise in early 20s may be shielded from osteoporosis 3Sloppy shipping of human retina leads IU researchers to discover new treatment path for eye disease 2Sloppy shipping of human retina leads IU researchers to discover new treatment path for eye disease 3Sloppy shipping of human retina leads IU researchers to discover new treatment path for eye disease 4MicroRNA controls malignancy and resistance of breast cancer cells 2
Rabbit polyclonal antibody to Glutathione-S-Transferase (GST)...
... Chromatograph/Mass Spectrometer, utilizing many of the ... offers high throughput and excellent productivity, ... ratio. Like the GCMS-QP2010 Plus, the ... for optimum separation, 20 temperature ramps, ...
Chicken polyclonal antibody to Glutathione-S-Transfrease (GST)...
... XS uniquely combines a single-channel sample processing ... 8-channel bulk reagent dispenser all in one ... using disposable pipette tips, the Precision XS ... dispenser is available for transferring larger volumes. ...
Biology Products: